T ROWE PRICE GROUP INC (TR1.DE) Fundamental Analysis & Valuation

FRA:TR1 • US74144T1088

Current stock price

77.35 EUR
+0.05 (+0.06%)
Last:

This TR1.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. TR1.DE Profitability Analysis

1.1 Basic Checks

  • TR1 had positive earnings in the past year.
  • TR1 had a positive operating cash flow in the past year.
  • In the past 5 years TR1 has always been profitable.
  • TR1 had a positive operating cash flow in each of the past 5 years.
TR1.DE Yearly Net Income VS EBIT VS OCF VS FCFTR1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • TR1's Return On Assets of 14.20% is amongst the best of the industry. TR1 outperforms 93.86% of its industry peers.
  • TR1 has a better Return On Equity (18.75%) than 81.58% of its industry peers.
  • TR1 has a Return On Invested Capital of 13.92%. This is amongst the best in the industry. TR1 outperforms 92.11% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for TR1 is above the industry average of 9.16%.
Industry RankSector Rank
ROA 14.2%
ROE 18.75%
ROIC 13.92%
ROA(3y)14.53%
ROA(5y)16.13%
ROE(3y)18.95%
ROE(5y)21.47%
ROIC(3y)14.02%
ROIC(5y)17.01%
TR1.DE Yearly ROA, ROE, ROICTR1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • TR1 has a better Profit Margin (27.84%) than 74.56% of its industry peers.
  • In the last couple of years the Profit Margin of TR1 has declined.
  • TR1 has a better Operating Margin (33.12%) than 71.93% of its industry peers.
  • TR1's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 33.12%
PM (TTM) 27.84%
GM N/A
OM growth 3Y-6.39%
OM growth 5Y-5.62%
PM growth 3Y5.88%
PM growth 5Y-5.62%
GM growth 3YN/A
GM growth 5YN/A
TR1.DE Yearly Profit, Operating, Gross MarginsTR1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. TR1.DE Health Analysis

2.1 Basic Checks

  • TR1 has less shares outstanding than it did 1 year ago.
  • TR1 has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for TR1 has been reduced compared to a year ago.
TR1.DE Yearly Shares OutstandingTR1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
TR1.DE Yearly Total Debt VS Total AssetsTR1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • TR1 has an Altman-Z score of 5.75. This indicates that TR1 is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 5.75, TR1 belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
  • The Debt to FCF ratio of TR1 is 0.01, which is an excellent value as it means it would take TR1, only 0.01 years of fcf income to pay off all of its debts.
  • TR1's Debt to FCF ratio of 0.01 is amongst the best of the industry. TR1 outperforms 98.25% of its industry peers.
  • TR1 has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • With an excellent Debt to Equity ratio value of 0.00, TR1 belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z 5.75
ROIC/WACCN/A
WACCN/A
TR1.DE Yearly LT Debt VS Equity VS FCFTR1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • TR1 has a Current Ratio of 3.95. This indicates that TR1 is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of TR1 (3.95) is better than 87.72% of its industry peers.
  • A Quick Ratio of 3.95 indicates that TR1 has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.95, TR1 belongs to the top of the industry, outperforming 87.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.95
Quick Ratio 3.95
TR1.DE Yearly Current Assets VS Current LiabilitesTR1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. TR1.DE Growth Analysis

3.1 Past

  • TR1 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.18%.
  • Measured over the past 5 years, TR1 shows a small growth in Earnings Per Share. The EPS has been growing by 0.25% on average per year.
  • TR1 shows a small growth in Revenue. In the last year, the Revenue has grown by 3.12%.
  • Measured over the past years, TR1 shows a small growth in Revenue. The Revenue has been growing by 3.34% on average per year.
EPS 1Y (TTM)4.18%
EPS 3Y6.66%
EPS 5Y0.25%
EPS Q2Q%15.09%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y4.08%
Revenue growth 5Y3.34%
Sales Q2Q%6.01%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.48% on average over the next years.
  • The Revenue is expected to grow by 2.06% on average over the next years.
EPS Next Y5.87%
EPS Next 2Y3.51%
EPS Next 3Y2.25%
EPS Next 5Y5.48%
Revenue Next Year4.58%
Revenue Next 2Y3.42%
Revenue Next 3Y2.93%
Revenue Next 5Y2.06%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TR1.DE Yearly Revenue VS EstimatesTR1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B
TR1.DE Yearly EPS VS EstimatesTR1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10

More info and screens

Find the best growth stocksShow best growing peers

8

4. TR1.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 9.19, the valuation of TR1 can be described as very reasonable.
  • Based on the Price/Earnings ratio, TR1 is valued cheaper than 85.96% of the companies in the same industry.
  • TR1 is valuated cheaply when we compare the Price/Earnings ratio to 24.88, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 8.67 indicates a reasonable valuation of TR1.
  • Based on the Price/Forward Earnings ratio, TR1 is valued cheaply inside the industry as 92.11% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of TR1 to the average of the S&P500 Index (22.19), we can say TR1 is valued rather cheaply.
Industry RankSector Rank
PE 9.19
Fwd PE 8.67
TR1.DE Price Earnings VS Forward Price EarningsTR1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TR1 indicates a rather cheap valuation: TR1 is cheaper than 90.35% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of TR1 indicates a rather cheap valuation: TR1 is cheaper than 88.60% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.16
EV/EBITDA 5.69
TR1.DE Per share dataTR1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • TR1's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • TR1 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.57
PEG (5Y)36.93
EPS Next 2Y3.51%
EPS Next 3Y2.25%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. TR1.DE Dividend Analysis

5.1 Amount

  • TR1 has a Yearly Dividend Yield of 5.97%, which is a nice return.
  • TR1's Dividend Yield is rather good when compared to the industry average which is at 3.25. TR1 pays more dividend than 89.47% of the companies in the same industry.
  • TR1's Dividend Yield is rather good when compared to the S&P500 average which is at 1.90.
Industry RankSector Rank
Dividend Yield 5.97%

5.2 History

  • The dividend of TR1 is nicely growing with an annual growth rate of 7.22%!
Dividend Growth(5Y)7.22%
Div Incr Years2
Div Non Decr Years2
TR1.DE Yearly Dividends per shareTR1.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • 56.13% of the earnings are spent on dividend by TR1. This is a bit on the high side, but may be sustainable.
  • TR1's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP56.13%
EPS Next 2Y3.51%
EPS Next 3Y2.25%
TR1.DE Yearly Income VS Free CF VS DividendTR1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
TR1.DE Dividend Payout.TR1.DE Dividend Payout, showing the Payout Ratio.TR1.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

TR1.DE Fundamentals: All Metrics, Ratios and Statistics

T ROWE PRICE GROUP INC

FRA:TR1 (3/26/2026, 7:00:00 PM)

77.35

+0.05 (+0.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-04
Earnings (Next)04-30
Inst Owners86.17%
Inst Owner ChangeN/A
Ins Owners1.71%
Ins Owner ChangeN/A
Market Cap16.87B
Revenue(TTM)7.31B
Net Income(TTM)2.04B
Analysts49.47
Price Target86.97 (12.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.97%
Yearly Dividend4.48
Dividend Growth(5Y)7.22%
DP56.13%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.29%
Min EPS beat(2)-3.09%
Max EPS beat(2)9.67%
EPS beat(4)3
Avg EPS beat(4)3.03%
Min EPS beat(4)-3.09%
Max EPS beat(4)9.67%
EPS beat(8)5
Avg EPS beat(8)3.34%
EPS beat(12)9
Avg EPS beat(12)5.61%
EPS beat(16)11
Avg EPS beat(16)2.69%
Revenue beat(2)0
Avg Revenue beat(2)-1.4%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)-1.12%
Revenue beat(4)0
Avg Revenue beat(4)-1.99%
Min Revenue beat(4)-2.98%
Max Revenue beat(4)-1.12%
Revenue beat(8)1
Avg Revenue beat(8)-2.77%
Revenue beat(12)2
Avg Revenue beat(12)-2.09%
Revenue beat(16)3
Avg Revenue beat(16)-2.77%
PT rev (1m)-4.62%
PT rev (3m)-8.93%
EPS NQ rev (1m)-0.1%
EPS NQ rev (3m)-2.23%
EPS NY rev (1m)-1.64%
EPS NY rev (3m)-1.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.16%
Revenue NY rev (1m)-0.75%
Revenue NY rev (3m)-0.61%
Valuation
Industry RankSector Rank
PE 9.19
Fwd PE 8.67
P/S 2.66
P/FCF 13.16
P/OCF 11.1
P/B 1.79
P/tB 2.45
EV/EBITDA 5.69
EPS(TTM)8.42
EY10.89%
EPS(NY)8.92
Fwd EY11.53%
FCF(TTM)5.88
FCFY7.6%
OCF(TTM)6.97
OCFY9.01%
SpS29.07
BVpS43.16
TBVpS31.57
PEG (NY)1.57
PEG (5Y)36.93
Graham Number90.42
Profitability
Industry RankSector Rank
ROA 14.2%
ROE 18.75%
ROCE 18.28%
ROIC 13.92%
ROICexc 18.68%
ROICexgc 29.02%
OM 33.12%
PM (TTM) 27.84%
GM N/A
FCFM 20.22%
ROA(3y)14.53%
ROA(5y)16.13%
ROE(3y)18.95%
ROE(5y)21.47%
ROIC(3y)14.02%
ROIC(5y)17.01%
ROICexc(3y)17.9%
ROICexc(5y)20.8%
ROICexgc(3y)27.61%
ROICexgc(5y)33.47%
ROCE(3y)18.47%
ROCE(5y)22.46%
ROICexgc growth 3Y-9.44%
ROICexgc growth 5Y-0.92%
ROICexc growth 3Y-5.68%
ROICexc growth 5Y-6.66%
OM growth 3Y-6.39%
OM growth 5Y-5.62%
PM growth 3Y5.88%
PM growth 5Y-5.62%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0.01
Cap/Depr 67.57%
Cap/Sales 3.75%
Interest Coverage 250
Cash Conversion 61.99%
Profit Quality 72.63%
Current Ratio 3.95
Quick Ratio 3.95
Altman-Z 5.75
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)118.35%
Cap/Depr(5y)115.41%
Cap/Sales(3y)4.83%
Cap/Sales(5y)4.25%
Profit Quality(3y)62.21%
Profit Quality(5y)86.61%
High Growth Momentum
Growth
EPS 1Y (TTM)4.18%
EPS 3Y6.66%
EPS 5Y0.25%
EPS Q2Q%15.09%
EPS Next Y5.87%
EPS Next 2Y3.51%
EPS Next 3Y2.25%
EPS Next 5Y5.48%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y4.08%
Revenue growth 5Y3.34%
Sales Q2Q%6.01%
Revenue Next Year4.58%
Revenue Next 2Y3.42%
Revenue Next 3Y2.93%
Revenue Next 5Y2.06%
EBIT growth 1Y1.88%
EBIT growth 3Y-2.57%
EBIT growth 5Y-2.47%
EBIT Next Year29.84%
EBIT Next 3Y12.02%
EBIT Next 5Y2.93%
FCF growth 1Y17.19%
FCF growth 3Y-11.33%
FCF growth 5Y-2.79%
OCF growth 1Y4.02%
OCF growth 3Y-9.42%
OCF growth 5Y-1.79%

T ROWE PRICE GROUP INC / TR1.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for T ROWE PRICE GROUP INC?

ChartMill assigns a fundamental rating of 7 / 10 to TR1.DE.


What is the valuation status of T ROWE PRICE GROUP INC (TR1.DE) stock?

ChartMill assigns a valuation rating of 8 / 10 to T ROWE PRICE GROUP INC (TR1.DE). This can be considered as Undervalued.


Can you provide the profitability details for T ROWE PRICE GROUP INC?

T ROWE PRICE GROUP INC (TR1.DE) has a profitability rating of 6 / 10.


Can you provide the financial health for TR1 stock?

The financial health rating of T ROWE PRICE GROUP INC (TR1.DE) is 9 / 10.


What is the expected EPS growth for T ROWE PRICE GROUP INC (TR1.DE) stock?

The Earnings per Share (EPS) of T ROWE PRICE GROUP INC (TR1.DE) is expected to grow by 5.87% in the next year.